Computational design of a PAK1 binding protein.
We describe a computational protocol, called DDMI, for redesigning scaffold proteins to bind to a specified region on a target protein. The DDMI protocol is implemented within the Rosetta molecular modeling program and uses rigid-body docking, sequence design, and gradient-based minimization of backbone and side-chain torsion angles to design low-energy interfaces between the scaffold and target protein. Iterative rounds of sequence design and conformational optimization were needed to produce models that have calculated binding energies that are similar to binding energies calculated for native complexes. We also show that additional conformation sampling with molecular dynamics can be iterated with sequence design to further lower the computed energy of the designed complexes. To experimentally test the DDMI protocol, we redesigned the human hyperplastic discs protein to bind to the kinase domain of p21-activated kinase 1 (PAK1). Six designs were experimentally characterized. Two of the designs aggregated and were not characterized further. Of the remaining four designs, three bound to the PAK1 with affinities tighter than 350 muM. The tightest binding design, named Spider Roll, bound with an affinity of 100 muM. NMR-based structure prediction of Spider Roll based on backbone and (13)C(beta) chemical shifts using the program CS-ROSETTA indicated that the architecture of human hyperplastic discs protein is preserved. Mutagenesis studies confirmed that Spider Roll binds the target patch on PAK1. Additionally, Spider Roll binds to full-length PAK1 in its activated state but does not bind PAK1 when it forms an auto-inhibited conformation that blocks the Spider Roll target site. Subsequent NMR characterization of the binding of Spider Roll to PAK1 revealed a comparably small binding 'on-rate' constant (<<10(5) M(-1) s(-1)). The ability to rationally design the site of novel protein-protein interactions is an important step towards creating new proteins that are useful as therapeutics or molecular probes.
Jha
Ramesh K
RK
Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7260, USA.
Leaver-Fay
Andrew
A
Yin
Shuangye
S
Wu
Yibing
Y
Butterfoss
Glenn L
GL
Szyperski
Thomas
T
Dokholyan
Nikolay V
NV
Kuhlman
Brian
B
D000595:Amino Acid Sequence; D003198:Computer Simulation; D006801:Humans; D008958:Models, Molecular; D056004:Molecular Dynamics Simulation; D008969:Molecular Sequence Data; D019906:Nuclear Magnetic Resonance, Biomolecular; D011485:Protein Binding; D011487:Protein Conformation; D016415:Sequence Alignment; D012984:Software; D054462:p21-Activated Kinases / Q000737:chemistry* / Q000235:genetics
D054462:p21-Activated Kinases
J Mol Biol. 2007 Oct 19;373(2):503-19
17825317
Trends Biotechnol. 2005 Sep;23(9):450-5
16038997
Curr Opin Chem Biol. 2004 Feb;8(1):91-7
15036162
Gene. 1995 Oct 16;164(1):49-53
7590320
Fold Des. 1998;3(6):577-87
9889167
Nature. 2009 Apr 16;458(7240):859-64
19370028
Proteins. 1999 May 1;35(2):133-52
10223287
Curr Opin Struct Biol. 2009 Aug;19(4):458-63
19646858
J Comput Chem. 2005 Sep;26(12):1222-32
15962277
J Mol Biol. 2003 Aug 1;331(1):281-99
12875852
Nat Biotechnol. 2004 May;22(5):575-82
15097997
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4685-90
18326625
Nature. 2008 May 8;453(7192):190-5
18354394
J Biomol NMR. 2000 Dec;18(4):311-8
11200525
Protein Sci. 1997 Aug;6(8):1661-81
9260279
Nucleic Acids Res. 2008 Jan;36(Database issue):D402-8
17984079
Methods Enzymol. 2004;383:66-93
15063647
J Mol Biol. 2003 Feb 28;326(4):1239-59
12589766
Nat Struct Biol. 2003 Jan;10(1):45-52
12459719
Annu Rev Biochem. 2008;77:363-82
18410248
Gene. 1989 Apr 15;77(1):51-9
2744487
Protein Sci. 2007 Dec;16(12):2770-4
18029425
Proteins. 1999 Jan 1;34(1):82-95
10336385
Cell. 2000 Aug 4;102(3):387-97
10975528
J Biomol NMR. 1995 Nov;6(3):277-93
8520220
Science. 1998 Nov 20;282(5393):1462-7
9822371
Proteins. 2008 Apr;71(1):320-35
17932929
Structure. 2008 Jul;16(7):1010-8
18611374
Curr Opin Struct Biol. 2002 Apr;12(2):204-13
11959498
J Biomol NMR. 1995 Jul;6(1):1-10
22911575
Nat Chem Biol. 2009 Nov;5(11):797-807
19841629
Structure. 2005 Aug;13(8):1131-41
16084385
J Comput Chem. 2007 Jun;28(8):1336-41
17285560
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4414-9
11287654
Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10383-8
10984534
Science. 2003 Nov 21;302(5649):1364-8
14631033
Nat Struct Mol Biol. 2005 Oct;12(10):933-4
16142244